Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinal cell surface receptors comprise a broad and heterogeneous group of proteins expressed on the plasma membranes of various cells within the retina, including photoreceptors, bipolar cells, ganglion cells, and the retinal pigment epithelium (RPE). These receptors are essential for the primary functions of the visual system, such as phototransduction (mediated by opsins like rhodopsin), synaptic transmission (mediated by glutamate and GABA receptors), and the maintenance of retinal homeostasis (mediated by growth factor and adhesion receptors). In pathological states, specific members of this class serve as critical therapeutic targets; for example, alpha-2 adrenergic and prostaglandin receptors are targeted to manage glaucoma, while integrins and Tie2 receptors are investigated for treating neovascular diseases like wet age-related macular degeneration. Additionally, certain surface receptors, such as heparan sulfate proteoglycans and nucleolin, are increasingly utilized as docking sites for viral vectors in gene therapy to facilitate cell-specific entry into the retina. Because this term refers to a wide category of proteins rather than a single molecular entity, pharmacological intervention requires high specificity to avoid off-target effects within the complex architecture of the eye.
Activation or inhibition of cell surface signaling pathways to modulate intraocular pressure, provide neuroprotection, or inhibit pathological angiogenesis and vascular leakage in the retina.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinal cell surface receptors.